Results 1 to 10 of about 75,061 (302)

Lymphaticovenular anastomosis for recurrent cellulitis in a dementia patient with lymphedema

Journal of Vascular Surgery Cases and Innovative Techniques, 2020
We describe a dementia patient with comorbid recurrent cellulitis and lymphedema in the left lower limb who was treated successfully for recurrent cellulitis by lymphaticovenular anastomosis (LVA).
Shuhei Yoshida, MD, PhD, Isao Koshima, MD, PhD, Hirofumi Imai, MD, Ayano Sasaki, MD, Shogo Nagamatsu, MD, PhD, Kazunori Yokota, MD, PhD   +5 more
doaj   +2 more sources

A rare truncal collateral lymph drainage pathway seen on indocyanine green lymphography in patients with secondary lower limb lymphedema

Journal of Vascular Surgery Cases and Innovative Techniques, 2023
Objective: Although collateral lymphatic vessels are known to develop in patients with lymphedema, little is known about their significance. In this study, we investigated truncal collateral lymphatic drainage pathways in patients with lower limb ...
Solji Roh, MD, Isao Koshima, MD, PhD, Toshiro Mese, MD, Hirofumi Imai, MD, Shuhei Yoshida, MD, PhD, Shuji Yamashita, MD, PhD   +5 more
doaj   +1 more source

Supermicrosurgical lymphatic venous anastomosis for intractable lymphocele after great saphenous vein harvesting graft

Journal of Vascular Surgery Cases and Innovative Techniques, 2022
Lymphoceles result from either trauma to the lymphatic vessels or after vein graft harvest, which occurs in 10% to 16% of patients. When a lymphocele persists despite conservative treatment, patients can experience undue distress.
Hirofumi Imai, MD, Shuhei Yoshida, MD, PhD, Toshiro Mese, MD, Solji Roh, MD, Isao Koshima, MD, PhD   +4 more
doaj   +1 more source

Successful Treatment of Rheumatoid Lymphedema with Lymphatic Venous Anastomosis

Plastic and Reconstructive Surgery, Global Open, 2021
Summary:. Rheumatoid lymphedema is a rare but severely disabling condition caused by reduced lymphatic drainage. Most treatment methods are conservative and may lead to the exacerbation of lymphedema.
Hirofumi Imai, MD, Shuhei Yoshida, MD, PhD, Toshio Uchiki, MD, Ayano Sasaki, MD, Shogo Nagamatsu, MD, PhD, Isao Koshima, MD, PhD   +5 more
doaj   +1 more source

THE NECESSITY OF COMPRESSION GARMENTS IN MANAGING LYMPHEDEMA

Journal of Cancer Rehabilitation, 2022
Background Lymphedema affects millions of cancer patients and survivors in the United States (US). The consequences of inadequately treated lymphedema include physiological changes that signi cantly impact their quality of life.
Said Nafai, Deborah Crow, Elizabeth W. Stevens-Nafai, Heather Ferguson   +3 more
doaj   +1 more source

Combined Treatment with Lymphaticovenular Anastomosis and Ethanol Sclerotherapy for Cystic Lymphangioma in a Limb

Plastic and Reconstructive Surgery, Global Open, 2022
Summary:. Several treatment options, including sclerotherapy and surgical excision, are available for the management of cystic lymphangioma. Lymphaticovenular anastomosis (LVA) has recently garnered attention in the field of microsurgery as a minimally ...
Shuhei Yoshida, MD, PhD, Hirofumi Imai, MD, Solji Roh, MD, Toshiro Mese, MD, Isao Koshima, MD, PhD   +4 more
doaj   +1 more source

A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis. [PDF]

, 2013
BACKGROUND: The success of programs to eliminate lymphatic filariasis (LF) depends in large part on their ability to achieve and sustain high levels of compliance with mass drug administration (MDA). This paper reports results from a comprehensive review
Fischer, Peter U, Krentel, Alison, Weil, Gary J   +2 more
core   +16 more sources

Cystic Lymphatic Malformation with Lymphedema Treated by Lymphaticovenular Anastomosis Combined with Ethanol Sclerotherapy

Plastic and Reconstructive Surgery, Global Open, 2023
The incidence of cystic lymphatic malformation (CL) in an extremity is very rare. CL can be a cause of lymphedema in a lower limb. The most effective treatment for CL is sclerotherapy or excision; however, these treatments have the potential to cause ...
Shuhei Yoshida, MD, PhD, Hirofumi Imai, MD, Solji Roh, MD, Toshiro Mese, MD, Isao Koshima, MD, PhD   +4 more
doaj   +1 more source

Feasibility of a Pilot Randomized Controlled Trial Examining a Multidimensional Intervention in Women with Gynecological Cancer at Risk of Lymphedema

Current Oncology, 2021
There is limited knowledge on non-invasive lymphedema risk-reduction strategies for women with gynecological cancer. Understanding factors influencing the feasibility of randomized controlled trials (RCTs) can guide future research. Our objectives are to
Shirin M. Shallwani, Anna Towers, Anne Newman, Shannon Salvador, Angela Yung, Lucy Gilbert, Walter H. Gotlieb, Xing Zeng, Doneal Thomas   +8 more
doaj   +1 more source

Cost of a lymphedema treatment mandate - 16 years of experience in the Commonwealth of Virginia

Health Economics Review, 2022
Background Treatment of chronic illness accounts for over 90% of Medicare spending. Chronic lymphedema places 3–10 million Americans at risk for recurrent cellulitis.
Robert Weiss
doaj   +1 more source